Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma-Reference-Cited by-同舟云学术

Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma

Published:2019-01 Issue:S1 Volume:12 Page:
ISSN:1755-8794
Container-title:BMC Medical Genomics
language:en
Short-container-title:BMC Med Genomics

Author:

Cheng Lijun,Pandya Pankita H.,Liu Enze,Chandra Pooja,Wang Limei,Murray Mary E.,Carter Jacquelyn,Ferguson Michael,Saadatzadeh Mohammad Reza,Bijangi-Visheshsaraei Khadijeh,Marshall Mark,Li Lang,Pollok Karen E.,Renbarger Jamie L.

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/s12920-018-0456-5.pdf

Reference46 articles.

1. HaDuong JH, Martin AA, Skapek SX, Mascarenhas L. Sarcomas. Pediatr Clin N Am. 2015;62(1):179–200.

2. Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetete-Lalami S, Rusch M, et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer discov. 2014;4(11):1342–53.

3. Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, Ambrogio L, Auclair D, Wang J, Song YK, et al. Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer discov. 2014;4(2):216–31.

4. Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, et al. The genomic landscape of pediatric Ewing sarcoma. Cancer discov. 2014;4(11):1316–41.

5. Martin JW, Squire JA, Zielenska M. The genetics of osteosarcoma. Sarcoma. 2012;2012:11.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying cell lines across pan-cancer to be used in preclinical research as a proxy for patient tumor samples;Communications Biology;2024-09-07

2. Copy number variations contribute to malignant tumor development in children with serious birth defects;Molecular Oncology;2024-08-14

3. Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape;Cancers;2024-04-25

4. Identifying squalene epoxidase as a metabolic vulnerability in high‐risk osteosarcoma using an artificial intelligence‐derived prognostic index;Clinical and Translational Medicine;2024-02

5. Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa;Journal of Bone Oncology;2023-12